Iridogoniodysgenesis, dominant type

From WikiMD's Medical Encyclopedia

Revision as of 01:36, 8 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Iridogoniodysgenesis, dominant type
Synonyms
Pronounce
Specialty Ophthalmology
Symptoms Iris abnormalities, glaucoma
Complications Vision loss, blindness
Onset Congenital
Duration Lifelong
Types
Causes Genetic mutation
Risks Family history
Diagnosis Clinical examination, genetic testing
Differential diagnosis Other anterior segment dysgenesis disorders
Prevention Genetic counseling
Treatment Glaucoma surgery, medication
Medication Topical beta-blockers, prostaglandin analogs
Prognosis Variable, depends on severity of glaucoma
Frequency Rare
Deaths N/A


Iridogoniodysgenesis, dominant type is a rare genetic disorder that affects the development of the iris and the anterior chamber of the eye. This condition is characterized by abnormalities in the iris and the trabecular meshwork, which can lead to glaucoma and other ocular complications.

Clinical Features[edit]

Individuals with iridogoniodysgenesis, dominant type, typically present with distinctive ocular features, including:

Genetics[edit]

Iridogoniodysgenesis, dominant type, is inherited in an autosomal dominant manner. This means that a single copy of the altered gene in each cell is sufficient to cause the disorder. The specific gene or genes involved in this condition are not yet fully understood, but it is known to be associated with mutations in genes that play a role in the development of the anterior chamber of the eye.

Diagnosis[edit]

The diagnosis of iridogoniodysgenesis, dominant type, is based on clinical examination and the identification of characteristic ocular features. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the condition.

Management[edit]

Management of iridogoniodysgenesis, dominant type, focuses on monitoring and treating glaucoma and other ocular complications. This may include:

Prognosis[edit]

The prognosis for individuals with iridogoniodysgenesis, dominant type, varies depending on the severity of the condition and the effectiveness of glaucoma management. Early diagnosis and appropriate treatment are crucial in preventing vision loss and other complications.

See also[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.